Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$2.01 - $3.0 $904 - $1,350
-450 Reduced 3.93%
11,000 $31,000
Q1 2021

Apr 30, 2021

BUY
$2.09 - $5.11 $940 - $2,299
450 Added 4.09%
11,450 $34,000
Q3 2020

Nov 05, 2020

BUY
$1.75 - $8.19 $1,750 - $8,189
1,000 Added 10.0%
11,000 $20,000
Q2 2019

Jul 26, 2019

BUY
$4.89 - $8.11 $48,900 - $81,100
10,000 New
10,000 $55,000

Others Institutions Holding VCNX

About VACCINEX, INC.


  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $287M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.